The portable light therapy device uses Bluewave technology to mimic the blue light of the long days of summer. Research has shown that blue light can be twice as effective as white light in combating the effects of winter blues. With the recommended use of light therapy, most people experiencing the winter blues should discover an increase in energy levels and mood. The compact size of the Philips goLITE makes it an easy device to use anywhere whether it’s in the bedroom, kitchen or office and it can fit easily into a person’s daily routine. Blue light technology can produce results with as little as 15 minutes of use per day of the device and is a natural way to deal with seasonal mood-related problems as well as sleep problems. Philips therapy lights with Bluewave technology restore the essential signals needed to regulate circadian rhythms. This form of light therapy is also beneficial to help prevent jet lag in those who travel across various time zones and for those who have shift work schedules that disrupt the body’s clock
The Philips goLITE features a unique compact design with advanced features including easy to set functions such as intensity, time and a treatment-reminder alarm. The Philips goLITE is now available in the pharmacy department of all London Drugs for $189.99. From February 5th to March 3rd the Philips goLITE will be available for $169.99 London Drugs pharmacists are available to discuss the variety of options that are available to assist with winter blues as well as work with other health care professionals to determine the best course of treatment. To find out more information about light therapy and other similar products visit your London Drugs to speak with a pharmacist.
About London Drugs
Founded in 1945, B.C.-based London Drugs currently has 69 stores in more than 35 major markets throughout British Columbia, Alberta, Saskatchewan and Manitoba. Renowned for its creative approach to retailing, the company employs more than 7,500 people and carries a diverse range of health and consumer electronic products. With its strong commitment to innovation and customer appreciation, London Drugs has established itself as a reputable and caring company and continues to position itself for future growth and development.
For more information or to arrange an interview/demonstration, please contact:
Cynnamon Schreinert, Media Relations, London Drugs
604-802-2733, cynnamon@shaw.ca
Wendy Hartley, Media Relations, London Drugs
604-817-2758, WendyHartley@telus.net